Cholera remains an important public health problem in many parts of the world and the availability of an effective cholera vaccine is important for the prevention of cholera in the countries affected by this disease. Despite the apearance in 1992 of a new serogroup, O139, of Vibrio cholerae, most of the cholera outbreaks are still caused by V. cholerae O1 biotype El Tor. Vaccine trials in Asia from 1968 to 1971, and studies of the production of serotypespecific antiserum in rabbits and of the protective activity of monoclonal antibodies against diarrhoeal disease in neonatal mice, have led to the conclusion that the Ogawa serotype contains a specific antigenic determinant whereas the Inaba serotype contains a different antigenic determinant that cross-reacts with the Ogawa serotype. By studying the binding of anti-Ogawa monoclonal antibodies to synthetic oligosaccharide fragments mimicking the Ogawa O-specific polysaccharide, it has been shown that the terminal monosaccharide, bearing the 2-O-methyl group in the O-specific polysaccharide, is most probably the serotype-specific determinant for the Ogawa strain. However, study of the binding of a monoclonal antibody recognizing both Ogawa and Inaba serotypes suggested partial recognition of the core as well as of the O-specific polysaccharide of the LPS of V. cholerae O1. To further characterize this antigenic determinant that is common to the Ogawa and Inaba serotypes, the core and the O-specific polysaccharide linked to the core of V. cholerae O1 LPS were purified by preparative electrophoresis. The O-specific polysaccharide linked to the core was subjected to periodate oxidation to destroy sugars from the core. Binding studies of these purified saccharide fragments to a monoclonal antibody which is protective in mice and specific to the antigenic determinant common to Ogawa and Inaba serotypes showed that both the core and the O-specific polysaccharide are involved in this common antigenic determinant. This explains how the presence or the absence of the Ogawa-specific antigenic determinant would lead to the expression of two independent antigenic determinants of V. cholerae O1, one specific to the Ogawa serotype and the other common to both Ogawa and Inaba serotypes.
INTRODUCTION
Cholera remains an important public health problem. The long-term control of cholera depends on good personal hygiene, an uncontaminated water supply and appropriate sewage disposal. However, the improvement of hygiene is a distant goal for many countries. Thus, the availability of an effective cholera vaccine is important for the prevention of cholera in these countries. Cholera is caused by Vibrio cholerae strains belonging to two serogroups, O1 and O139, based on their LPS structure. Serogroup O1, which is responsible for the seventh cholera pandemic, is divided into three serotypes, Inaba, Ogawa and Hikojima (a variant of the Ogawa serotype) (Stroeher et al., 1992) . Vaccine trials in Asia from 1968 to 1971 showed that killed whole-cell Inaba vaccines protected against both Inaba and Ogawa cholera, whereas Ogawa vaccine protected only against Ogawa cholera (Mosley et al., 1970 (Mosley et al., , 1973 Philippines Cholera Committee, 1973 ; Levine & Pierce, 1992) . A conjugate vaccine composed of the detoxified LPS of V. cholerae O1 serotype Inaba bound to cholera toxin elicits vibriocidal antibodies against both Ogawa and Inaba serotypes (Gupta et al., 1992 (Gupta et al., , 1998 . The results obtained with mAbs tested for their protective activity against diarrhoeal disease in neonatal mice are consistent with the findings with vaccines. Several mAbs directed against V. cholerae O1 have been prepared (Gustafsson et al., 1982 ; Gustafsson & Holme, 1983 , 1985a Gustafsson, 1984 ; Brayton et al., 1987 ; Sugiyama et al., 1987 ; Adams et al., 1988 ; Winner et al., 1991 ; Colwell et al., 1992 ; Apter et al., 1993 ; Bougoudogo et al., 1995 ; Ramamurthy et al., 1995 ; Lu$ llau et al., 1996) . Most of these mAbs were studied for diagnostic purposes and only three mAbs have been tested for their protective activity in mice (Winner et al., 1991 ; Apter et al., 1993 ; Bougoudogo et al., 1995) . A secretory IgA (clone 2D6) and an IgG (clone S-20-3\S-20-4), both obtained by immunization with an Ogawa strain and directed against the Ogawa serotype, were associated with protection against the homologous serotype (Winner et al., 1991 ; Apter et al., 1993 ; Bougoudogo et al., 1995) . An IgG (clone I-24-2) obtained by immunization with an Inaba strain and directed against both the Ogawa and Inaba serotypes protected neonatal mice against both serotypes (Bougoudogo et al., 1995) . Therefore, observations made during cholera vaccine trials and experimental cholera in mice suggest that the Ogawa serotype contains a specific antigenic determinant whereas the Inaba serotype contains a different antigenic determinant that cross-reacts with the Ogawa serotype.
The Ogawa and Inaba serotypes of V. cholerae O1 differ only by a 2-O-methyl group that is present in the nonreducing terminal sugar of the Ogawa O-specific polysaccharide (O-SP) of the LPS, but is absent from the Inaba O-SP (Hisatsune et al., 1993 ; Ito et al., 1994 ; Wang et al., 1998) . Studies with mAb S-20-3\S-20-4 directed against Ogawa LPS and synthetic methyl α-glycosides of oligosaccharide fragments mimicking the Ogawa O-SP show that the terminal monosaccharide defines, as its major component, the serotype-specific antigenic determinant for the Ogawa strain (Wang et al., 1998) . It is thus most likely that the protection induced in vaccine trials by Ogawa whole-cell vaccines is due to the induction of antibodies recognizing only this serotype-specific antigenic determinant. This would explain why the vaccine does not protect against the Inaba serotype. In contrast, the binding of mAb I-24-2 (which recognizes both serotypes) to Ogawa LPS is somewhat puzzling (Wang et al., 1998) . MAb I-24-2, like whole-cell Inaba vaccine, induces protection in mice against both the Ogawa and Inaba serotypes, and it is therefore likely that the antigenic determinant recognized by this mAb would be useful to induce protective antibodies against both serotypes. To further characterize this antigenic determinant, we investigated the binding of purified saccharide fragments from V. cholerae O1 LPS to mAbs I-24-2 and S-20-3\S-20-4 by immunoblotting and ELISA inhibition. We found that the core and the O-SP are both involved in the antigenic determinant common to the Ogawa and Inaba serotypes. This would explain how the presence or the absence of a single 2-O-methyl group in the nonreducing terminal residue of the O-SP chains of the LPS could lead to the expression of two independent antigenic determinants, one specific to the Ogawa serotype and the other common to both the Ogawa and Inaba serotypes.
METHODS
Bacterial strains and growth conditions. The V. cholerae serogroup O1 strains used in this study were of the El Tor biotype. The serotype Ogawa strain (CNRVC 920172) was isolated in 1987 in France from a case of cholera imported from Algeria. The serotype Inaba strain (CNRVC 950707) was isolated in 1995 from a patient in Mali. Cells were grown in Tryptic soy agar (Difco) in Roux flasks at 37 mC for 18 h.
Monoclonal antibodies. mAb I-24-2 is an IgG $ recognizing LPS from both Ogawa and Inaba serotypes. mAb S-20-3\S-20-4 is an IgG " specific for serotype Ogawa LPS. Production, biological activity and the cDNA-derived amino acid sequence of both mAbs have been described elsewhere (Bougoudogo et al., 1995 ; Wang et al., 1998) .
Preparation of LPSs and derived fragments. Cultures were suspended in distilled water and LPS was obtained by hot phenol\water extraction (Westphal & Jann, 1965) , followed by enzymic treatment (DNase, RNase and protease) and ultracentrifugation (100 000 g for 3 h). The pellet containing LPS was dialysed against distilled water and freeze-dried. The LPS preparations from each serotype contained 1 % (w\v) protein and less than 0n2% (w\v) nucleic acid. Inaba LPS was detoxified by acid hydrolysis (Hancock & Poxton, 1988) : LPS (10 mg ml − " in 1 % aqueous acetic acid) was heated at 100 mC for 60 min. The samples were subjected to low-speed centrifugation (350 g for 10 min) to precipitate lipid A, and the supernatant containing the polysaccharide moiety of the LPS collected. It was extracted with an equal volume of chloroform\ethanol (2 : 1), shaken vigorously and centrifuged (10 000 g for 30 min). The aqueous phase was dialysed against distilled water to remove ethanol and freeze-dried.
The oxidized and reduced (O\R) polysaccharide moiety of the LPS was isolated by Smith-type degradation of the polysaccharide moiety of the LPS (Goldstein et al., 1970 ; Le Blay et al., 1994) , involving oxidation in 1 % (w\v) aqueous sodium periodate at 20 mC for 2 d in the dark, dialysis and freezedrying followed by reduction in 0n6% (w\v) sodium borohydride solution at 20 mC for 6 h, acid hydrolysis (2 %, v\v, acetic acid) at 100 mC for 2 h and purification by Sephadex G-25 chromatography. Several sugars of the core, containing vicinal diols, are susceptible to this treatment, whereas the O\R polysaccharide moiety of the LPS [consisting of (1 2 (Kenne et al., 1982 ; Gupta et al., 1992) .
α--mannopyranosyl residues] is resistant (Kenne et al., 1982 ; Vinogradov et al., 1995 ; Wang et al., 1998) .
The polysaccharide moiety of the LPS was subjected to preparative PAGE (prep-PAGE) on a model 491 Prep Cell apparatus (Bio-Rad), using deoxycholic acid (DOC) buffer as described by Krauss et al. (1988) . A 6 cm, 12 % polyacrylamide resolving gel (12 % acrylamide, 0n35 % bisacrylamide, 0n5% DOC, 375 mM Tris base, pH 8n8) was cast according to the manufacturer's recommendations. The resolving gel was then overlaid with a 0n5 cm stacking gel (4 % acrylamide, 0n1% bisacrylamide, 0n5 % DOC, 250 mM Tris base, pH 8n8). Before electrophoresis, the polysaccharide moiety of the LPS sample [0n75 % (w\v) polysaccharide moiety of the LPS in 0n25 % DOC, 10 % (v\v) glycerol, 8 % β-mercaptoethanol, 0n05 % bromophenol blue, pH 6n8] was heated at 100 mC for 10 min. The sample was loaded onto the gel and subjected to electrophoresis at 30 mA. Fractions (2 ml) were collected for up to 10 h after the tracking dye had eluted. Three bands were obtained. Fractions corresponding to bands I and II were pooled (pool I) and fractions corresponding to band III were pooled (pool II). These pools were separately dialysed against 10 % ethanol at room temperature to remove buffer salts and DOC as previously described (Reuhs et al., 1993) , and freezedried.
SDS-PAGE analysis. LPS, the polysaccharide moiety of the LPS and the prep-PAGE fractions were analysed by Tricine SDS-PAGE (Scha$ gger & Von Jagow, 1987 ; Lesse et al., 1990) , using a 16n5 % running gel and a 4 % stacking gel. The cathode buffer (pH 8n25) consisted of 0n1 M Tris base, 0n1 M Tricine and 0n1 % SDS and the anode buffer (pH 8n9) consisted of 0n2 M Tris base. Gels were fixed overnight at 4 mC in 25% (v\v) propan-2-ol, 7 % acetic acid and silver stained as described by Tsai & Frasch (1982) .
Immunoblot analysis. Polysaccharides separated by Tricine SDS-PAGE were electrophoretically transferred to nitrocellulose (0n2 µm pore size ; Bio-Rad) at constant voltage (100 V) for 1n5 h in 25 mM Tris base, 192 mM glycine, 20 % ethanol, pH 8n3. The nitrocellulose was then soaked overnight at 4 mC in 3 % BSA in PBS. The membrane was washed three times by shaking gently for 5 min in Tween (0n1 %) in PBS (PBSTween). It was then gently shaken at room temperature for 2 h in 3 µg mAb I-24-2 ml − " in PBS-Tween containing 0n5% gelatin. The membrane was washed three times for 5 min each in PBS-Tween and incubated with a 1\800 dilution of alkalinephosphatase-conjugated goat anti-mouse IgG (heavy-and light-chain specific ; Biosys) in PBS-Tween with 0n5 % gelatin for 60 min at room temperature with gentle shaking. The membrane was washed and the blot developed by gently shaking for 10 min at room temperature in 1 g 5-bromo-4-chloro-3-indolyl phosphate nitro blue tetrazolium l − " (Sigma Fast ; Sigma) in distilled water.
ELISA inhibition. The amount of antigen giving 50 % inhibition of antibody binding was determined by a two-step ELISA. In step 1, mAb was incubated with solutions of polysaccharides and in step 2, the resulting mixtures of free and bound antibody were added to microtitre plates coated with serotype Ogawa or Inaba LPSs. The experiment was carried out as follows. Flat-bottom microplates (Immuno Microwell ; Nunc) were blocked by incubation with 0n5 % gelatin (Prolabo) in PBS for 1 h at 37 mC and washed with PBS containing 0n1% Tween-20. Polysaccharide dilutions (100 µl) and 100 µl mAb in PBS-Tween-gelatin were added to the wells, at a dilution, determined by direct ELISA titration, giving an A %*# of 0n5. The mixture was incubated for 1 h at 37 mC and 100 µl samples from each well were transferred to a second plate, that had been previously coated by incubation for 1 h at 37 mC with purified serotype Ogawa or Inaba LPSs (5 µg ml − ") in carbonate\bicarbonate buffer (0n1 M, pH 9n5), blocked with gelatin and washed with PBS-Tween. This plate was incubated at 37 mC for 1 h and washed with PBS-Tween. An anti-mouse peroxidase-conjugated IgG (heavy-and light-chain specific) (Sanofi Diagnostic Pasteur) diluted 1 in 1000 in PBS-Tween containing 0n5 % gelatin was added to the wells. The plate was incubated at 37 mC for 45 min and washed with PBS-Tween. The enzyme substrate (o-phenylenediamine dihydrochloride ; Sigma ; 100 µl at 0n4 mg ml − ") in 0n1 M sodium citrate (pH 5n2), containing 0n02 % hydrogen peroxide, was added to each well and the plate incubated for 10 min at room temperature. The reaction was stopped by adding 3 M HCl (50 µl per well) and the A %*# was read in an EL 800 spectrophotometer (Bio-Tek Instruments). The degree of inhibition was calculated as percentage inhibition l [(A −inhibitor kA +inhibitor )\ A −inhibitor )]i100.
Analytical methods. Protein was determined by the Lowry method with BSA as the standard. Double immunodiffusion was performed in 1 % agarose in 0n5 M NaCl for 18 h at 4 mC. The LPS concentration, assayed by the Limulus amoebocyte lysate (LAL) assay (Bio-Whittaker), is expressed in endotoxin units relative to the US standard (Hochstein, 1990) . NMR data were recorded on a BRUKER AC 300P spectrometer. The "$C NMR spectrum was acquired with composite pulse decoupling, "H decoupling, 64K data points, 60 kHz spectral window (1n7 s acquisition time) and 3n0 s delay between pulse cycles. Prior to Fourier transformation, each free-induction-decay signal was exponentially multiplied so as to result in an additional 3 Hz line, broadening the frequency domain spectrum. Forty milligrams of the Inaba polysaccharide moiety of the LPS was exchanged twice with D # O and dissolved in 0n5 ml D # O. The spectrum was recorded at ambient probe temperature (23 mC), using dioxan as an external reference (δ ! l 67n4 p.p.m.). Samples for electrospray mass spectrometry were dissolved in water\methanol\formic acid (50 : 50 : 0n1, by vol.). They were introduced into an API 365 triple-quadruple mass spectrometer (Perkin Elmer-Sciex) at a rate of 5 µl min − " with a syringe pump (Harvard Apparatus). The mass spectrometer was equipped with an atmospheric pressure ion source which was used to sample positive ions produced from a pneumatically assisted electrospray interface. The ionspray probe tip was held at 4n5 kV and the orifice voltage was set at 60 V. The mass spectrometer scanned continuously from m\z 400 to 1400 with a scan step of 0n1 and a dwell time per step of 2n0 ms, resulting in a scan duration of 20n0 s. Ten scans were averaged for each analysis. Mass calibration of the instrument was carried out by matching ions of polypropylene glycol to known reference masses stored in the calibration table of the spectrometer.
RESULTS

Characterization of LPSs and derived fragments
A yield of 38 mg polysaccharide moiety was obtained from 100 mg Inaba LPS. The serotype Inaba LPS had 5i10$ endotoxin units µg −" and the corresponding polysaccharide moiety of the LPS had 5 endotoxin units µg −" as assessed by the LAL assay ; this 1000-fold reduction was consistent with previous data (Gupta et al., 1992) . The "$C NMR spectrum of the polysaccharide moiety of the LPS (Fig. 1) has 9 major signals with chemical shifts identical to, or slightly shifted in position from, those reported for detoxified V. cholerae O1 LPS (Kenne et al., 1982 ; Gupta et al., 1992) .
As described for the Inaba LPS (Bougoudogo et al., 1995) , two main bands were detected by silver staining of SDS-PAGE gels containing the purified Inaba polysaccharide moiety of the LPS (Fig. 2a, lane 2) . Fig. 3 shows the profile of the LPS polysaccharide moiety subjected to prep-PAGE. Three bands were obtained, with M r values of 2500, 4000 and 14 000. Pool I (60-160 ml), corresponding to bands I and II, had a M r of 2000 (Fig. 2a, lane 4) . These two bands were pooled because they have been previously described to compose the core polysaccharide (Gustafsson & Holme, 1985b) . The difference between the observed M r of pool I (compare Fig. 2 and Fig. 3 ) was probably due to a difference in the amount of loaded product. Pool II (280-580 ml), corresponding to band III, had a M r of 14 000 (Fig. 2a, lane 3) .
The polysaccharide moiety of the LPS (Fig. 2b, lane 2 Fig. 4 . Double immunodiffusion analysis of Inaba LPS and derived fragments. Wells : 1, mAb I-24-2, 3 mg ml − 1 ; 2, LPS, 10 mg ml − 1 ; 3, polysaccharide moiety of the LPS, 10 mg ml − 1 ; 4, prep-PAGE pool II, 10 mg ml − 1 ; 5, prep-PAGE pool I, 10 mg ml − 1 .
immunoblotting. mAb I-24-2 recognized only pool II. Pool I contained less than 0n05 % (w\v) of the polysaccharide present in pool II because the detection threshold of pool II, determined in a separate experiment, was 10 ng. Double immunodiffusion detected a single precipitate between mAb I-24-2 and the Inaba LPS (Fig. 4, Inaba LPS 0n35 0n35 100 Ogawa LPS 3n00 3n00 50n00 Inaba O-SP linked to the core 0n40 0n30 100 Inaba O\R polysaccharide 4n00 5n00 100 moiety of the LPS Inaba core 6n00 8n00 100 E. coli LPS 100 100 100
and 2). A single precipitate was also observed when mAb I-24-2 was tested against the polysaccharide moiety of the LPS (Fig. 4, wells 1 and 3 ) and against the pool II (Fig. 4, wells 1 and 4) . The fusion of immunoprecipitation lines indicates immunochemical identity of Inaba LPS, the polysaccharide moiety of the LPS and pool II. However, no precipitate was observed when mAb I-24-2 was tested against pool I (Fig. 4, wells 1 and 5).
Electrospray mass spectrometry of pool I gave a molecular ion at m\z l 1650, consistent with the structure proposed for the core of V. cholerae O1 LPS (Vinogradov et al., 1995) (Fig. 5) . No higher-molecularmass component was observed in pool I, indicating that pool I was free of the species making up pool II or that any such contamination was only minor. Electrospray mass spectrometry of pool II (data not shown) gave a heterogeneous spectrum consistent with the O-SP of V. cholerae O1 being made up of 12-18 residues resulting in (1 2)-linked linear 4,6-dideoxy-4-(3-deoxy--glycero-tetronamido)-α--mannopyranosyl homopolymers (Kenne et al., 1982) . Thus the Inaba polysaccharide moiety of the LPS is a mixture of O-SP linked to the core and of free core. The O-SP linked to the core was isolated by prep-PAGE as pool II and the free core as pool I. 
Reactivity of mAbs I-24-2 and S-20-3/S-20-4 with Ogawa and Inaba LPSs and derived fragments
We investigated the fine specificity of recognition of these two mAbs by studying their interaction with the polysaccharides described above by ELISA inhibition. Controls were run to check the specificity of the binding. Only Ogawa LPS inhibited mAb S-20-3\S-20-4 binding to Ogawa LPS itself (Table 1 and Fig. 6c ). Escherichia coli LPS did not inhibit binding of the mAb S-20-3\S-20-4 or I-24-2 to either Ogawa or Inaba LPSs (Table 1 and Fig. 6 ).
Both Ogawa and Inaba LPSs inhibited the binding of mAb I-24-2 to LPSs from the two serotypes (Fig. 6a, b) . However, for 50 % inhibition of binding, almost ten times more Ogawa LPS than Inaba LPS was required (Table 1 , 3n00 µg ml −" and 0n35 µg ml −" , respectively). This shows that the antigenic determinant recognized by mAb I-24-2 is associated with the LPS from both serotypes although to a lesser degree with Ogawa LPS.
Binding of mAb I-24-2 to Ogawa and Inaba LPSs was also inhibited by the Inaba O-SP linked to the core (Fig.  6a, b ). This preparation was as effective as the native Inaba LPS at inhibiting binding of Ogawa and Inaba LPSs to mAb I-24-2 (Table 1 , 0n3-0n4 µg ml −" and 0n35 µg ml −" ). Thus the O-SP linked to the core contains an antigenic determinant common to both Ogawa and Inaba serotypes.
In contrast, the O\R polysaccharide moiety of the Inaba LPS was less effective than the native Inaba LPS at inhibiting binding of Ogawa and Inaba LPSs to mAb I-24-2 (Table 1 , 4-5 µg ml −" and 0n35 µg ml −" ). This is consistent with one or more sugar residues in the core that are sensitive to the periodate being involved in the antigenic determinant recognized by mAb I-24-2. As could be predicted from this observation, the core inhibited the binding of both Ogawa LPS and Inaba LPS to mAb I-24-2 (Table 1 , 6-8 µg ml −" ), indicating that the core is involved in the antigenic determinant common to Ogawa and Inaba serotypes and recognized by mAb I-24-2. These results show that both the core and the O-SP are involved in the Ogawa-Inaba common antigenic determinant.
DISCUSSION
IgG $ I-24-2 protects neonatal mice against Vibrio cholerae O1 serotypes Ogawa and Inaba (Bougoudogo et al., 1995) . The reactivity of this mAb against Ogawa LPS and Inaba LPS has been studied by measuring the inhibitory effects of synthetic oligosaccharide fragments mimicking the Inaba O-SP and of sugars from the core (Wang et al., 1998) . These experiments indicated partial specificity for the core as well as for a single residue of the O-SP of the LPS. Our findings with polysaccharide fragments purified from V. cholerae O1 LPS are entirely consistent with the antigenic determinant common to Ogawa and Inaba serotypes and recognized by mAb I-24-2 being mediated by the O-SP and the core of the LPS. This location for an antigenic determinant is unusual but is similar to that identified in LPS from Bordetella bronchiseptica (Le Blay et al., 1994) . The antigenic determinant recognized by mAb I-24-2 is common to Ogawa and Inaba LPSs, and must therefore be either the A or the C antigen described in V. cholerae O1 LPS (Sakazaki & Tamura, 1971) . Iredell et al. (1998) used immunogold electron microscopy to determine the relative amounts of the A, B and C antigens on Ogawa and Inaba cells. The A and C antigens were present on both Ogawa and Inaba cells. However, the amount of C antigen present on Ogawa cells was about half that detected on Inaba cells, and the A antigen appeared more abundant on Ogawa cells. In our experiments, the binding of IgG $ I-24-2 to Ogawa and Inaba LPSs was more strongly inhibited by the Inaba LPS than by the Ogawa LPS. It is therefore possible that the antigenic determinant recognized by mAb I-24-2 is the C antigen.
Ogawa-Inaba antigen from V. cholerae O1 Iredell et al. (1998) have suggested that the lack of methylation of the O-SP exposes the C antigen resulting in the Inaba serotype. Our results are completely consistent with this suggestion because the 2-O-methyl group in the non-reducing terminal residue of the O-SP on Ogawa cells may hamper recognition by the immune system of an antigenic determinant expressed by the O-SP linked to the core of the LPS.
Inaba strains are rfbT mutants of an Ogawa strain in which B antigen synthesis (i.e. methylation of the O-SP at its non-reducing end) is inactivated (Stroeher et al., 1992 ; Hisatsune et al., 1993) . Ogawa O-SP is defined as bearing a 2-O-methylated non-reducing terminal residue, but not all Ogawa O-SP chains are methylated (Iredell et al., 1998) . Thus, if 2-O-methylated O-SP chains express the B antigen and non-methylated O-SP chains express the C antigen, it is possible to account for the presence or absence of a 2-O-methyl group in the non-reducing terminal residue of the O-SP chains, leading to either serotype Ogawa or Inaba. In this case, as reported, Inaba cells, containing only non-2-Omethylated O-SP, would express the C antigen only, whereas Ogawa cells, containing both 2-O-methylated-O-SP chains and, to a lesser extent, non-2-O-methylated chains, would express both B and C antigens.
The identification of the Ogawa and Inaba serotypes of V. cholerae O1 is based on the use of specific agglutinating antisera produced by rabbits immunized with heat-inactivated whole bacterial cells of either Ogawa or Inaba serotype. However, cross-absorption of these sera is needed to improve their specificity. Ogawa serotype-specific antiserum is easy to obtain by absorption with bacteria of the Inaba serotype (Donovan & Furniss, 1982) . In contrast, Inaba serotype-specific antiserum is difficult to produce since there is often a concomitant loss of Inaba serotype-specific antibodies during the absorption with bacteria of the Ogawa serotype (Donovan & Furniss, 1982) . The presence of small amounts of the C antigen in Ogawa cells renders the absorption step difficult because antibodies directed against the C antigen are also adsorbed. As Inaba cells do not express the B antigen, they are the cells of choice in the adsorption step for producing a specific antiOgawa serum.
In conclusion, our results explain how the presence or the absence of the Ogawa-specific antigenic determinant would lead to the expression of two independent antigenic determinants of V. cholerae O1, one specific to the Ogawa serotype and the other common to both Ogawa and Inaba serotypes.
